Vyriad, Inc. Raises $29.5M In Series B Funding Led By Renowned Genetics Entrepreneur
Amount Raised
$29.5 Million
Round Type
Series B
RochesterBiotechnologyHealth CareScience And EngineeringDescription
Vyriad, Inc., a clinical-stage biotechnology company developing oncolytic virus therapies to treat a wide range of cancers, today announced $29.5M in new funding led by Mr. Harry Stine of Stine Seed Farms, Inc. with participation from existing investors. Stine Seed Farms joins Mayo Clinic, Mirae Asset, Regeneron Pharmaceuticals Inc., Southeast Minnesota Capital Fund (SMCF), and several high-net-worth individuals on the Vyriad investment roster
Quick answer
Vyriad raised $29.5 Million in a Series B round, dated May 17, 2022. Vyriad is based in Rochester, New York, United States.
- How much did Vyriad raise?
- Vyriad raised $29.5 Million in a Series B round on May 17, 2022.
- What does Vyriad do?
- Vyriad is a clinical-stage biotechnology company developing targeted genetic medicines for cancer and other serious diseases.
- Where is Vyriad based and how big is it?
- Vyriad is based in Rochester, New York, United States. Fundz records about 52 employees.
- Who are the decision-makers at Vyriad?
- Fundz holds 2 contacts at Vyriad, including the EVP. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Science And Engineering and Biotechnology around the same time
Companies in the same sectors as Vyriad that raised within 45 days of this round, from Fundz verified event records.
- Advanced NanoTherapies raised $7.2M (Series A) on June 28, 2022.
- PineTree Therapeutics raised $24M (Series A) on June 7, 2022.
- Upstream Bio raised $200M (Series A) on June 2, 2022.
- 22nd Century raised $58M on May 25, 2022.
- OliX Pharmaceuticals raised $45M (Funding Round) on May 25, 2022.
- Moma Therapeutics raised $150M (Series B) on May 10, 2022.
Who to call at Vyriad, and when
A new round usually means Vyriad is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Vyriad raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Vyriad, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Vyriad. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Vyriad raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansVyriad raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.